No description available.

A multitude of research supports that fluctuations in fertility and hormonal shifts in normally cycling females influence changes in female sexual strategies, preferences, and desires across the menstrual cycle. Evolutionary theory posits that in order to maximize reproductive benefits, near ovulation female responses to sexual stimuli alter and cues of sex are more appealing. The post-auricular reflex (PAR) is a psychophysiological reaction that has been linked to motivation and reward, emotion, and appetitive responding. The PAR responds to pleasant stimuli, including stimuli that are relevant to evolutionary themes. The purpose of the current study was to explore the nature of the post-auricular reflex, and in particular, to examine potential shifts in motivation and reward processing of sexual and emotional stimuli across the female menstrual cycle. Ovulation blunted PAR responses to non-erotic categories in normally cycling females, while responses to erotica did not significantly decrease across phases of the menstrual cycle. Ovulation was also found to affect female self-report of sexual desire. These shifts were not seen in females using hormonal birth control. The study results suggest that ovulation shifts female priorities towards reproduction by increasing desire and also decreasing motivations for non-mate-relevant activities. The study also demonstrates the need for greater investigation of the PAR and the appetitive responding system. / Psychology

Yes / OBJECTIVES: Variation in plasma hormone levels influences the neurobiology of brain regions involved in cognition and emotion processing. Fluctuations in hormone levels across the menstrual cycle could therefore alter cognitive performance and wellbeing; reports have provided conflicting results, however. The aim of this study was to assess whether objective assessment of cognitive performance and self-reported wellbeing during the follicular and luteal phases of the menstrual cycle is feasible and investigate the possible reasons for variation in effects previously reported. METHODS: The Cambridge Neuropsychological Test Automated Battery and Edinburgh Postnatal Depression Scale were used to assess the cognitive performance and wellbeing of 12 women. Data were analysed by self-reported and hormone-estimated phases of the menstrual cycle. RESULTS: Recruitment to the study and assessment of cognition and wellbeing was without issue. Plasma hormone and peptide estimation showed substantial individual variation and suggests inaccuracy in self-reported menstrual phase estimation. CONCLUSION: Objective assessment of cognitive performance and self-assessed wellbeing across the menstrual cycle is feasible. Grouping data by hormonal profile rather by self-reported phase estimation may influence phase-mediated results. Future studies should use plasma hormone and peptide profiles to estimate cycle phase and group data for analyses.

Treatment success in IVF-ICSI is mainly limited by female age, but differences in ovarian reserve (OR; the remaining pool of oocytes and their quality) between individuals modify treatment prerequisites among women of similar age. OR may be assessed by OR tests (ORTs). The main aims of this work were to study menstrual cycle length (MCL), basal levels of circulating gonadotrophins, antral follicle count (AFC) and serum Anti-Müllerian hormone (AMH) levels and their associations with and prognostic capacities regarding IVF-ICSI outcome in large cohorts of unselected women. Age-adjusted MCL was positively and linearly associated with pregnancy rates (PRs), live-birth rates (LBRs) and ovarian response to controlled ovarian hyperstimulation. An MCL of >34 days almost doubled the LBR compared with an MCL of <26 days. The grouped variable ‘combined FSH and LH levels’ was superior to both individual gonadotrophin levels and the LH:FSH ratio. The highest mean PR was seen in connection with a combination of FSH <6.7 U/l with LH >4.9 U/l; PRs were lowest when FSH-LH levels were opposite to this (high-low) and intermediate when FSH-LH levels were low-low or high-high. Associations with LBR and ovarian response were similar as those for PR. AFCs and serum AMH levels were positively and log-linearly associated with PR, LBR and ovarian response. Success rates levelled out above AFC 30 or AMH 5 ng/ml. Treatment outcome was superior among women with polycystic ovaries. Among the studied ORTs, logAFC and logAMH concentration correlated most strongly. After multivariate testing, entering all studied ORTs, AMH and female age remained independently associated with LBR. AMH + AFC + age predicted both poor and excessive ovarian responses with high accuracy. Adjusting for age and oocyte yield, all ORTs remained significant for LBR, implying that ORTs also capture information on oocyte quality. In conclusion, measures of OR are strongly associated with PR, LBR and ovarian response in a log-linear fashion, and partly reflect oocyte quality. The OR spectrum is continuous, from small ‘oligofollicular’ ovaries (the low extreme) to polycystic ovaries (the high extreme). Among the studied ORTs, AMH together with age provide the most powerful basal estimate for IVF/ICSI outcome.

A visibilidade da etapa fértil na mulher é uma questão polêmica e tem sido muito discutida nas últimas décadas. Alguns autores argumentam que no transcorrer da evolução a ovulação ficou oculta. Em paralelo, outros pesquisadores afirmam que a ovulação na mulher não se manifesta de forma tão visível como em alguns primatas que apresentam sinais muito notórios da ovulação, por exemplo, a tumefação vaginal. Mas diversas pesquisas têm fornecido evidência que mostram que o período fértil na mulher é perceptível de maneira sutil, sem que se tenha consciência do processo perceptual envolvido. Os achados destas pesquisas apontam para o fato de diversas características (como a face, a proporção cintura quadril, a simetria de tecidos brandos pareados e o cheiro) serem percebidas como mais atraentes na etapa fértil. O presente estudo teve por objetivo investigar se em alguma etapa (folicular tardia ou lútea) do ciclo menstrual a face da mulher se torna mais atraente para o sexo oposto devido a mudanças morfológicas induzidas pelos níveis hormonais. Foram apresentados, apenas para participantes masculinos, 36 slides com fotografias de faces frontais de mulheres em idade reprodutiva. Em cada slide foram mostradas simultaneamente duas fotos da mesma mulher, uma das fotos obtida na Fase Folicular Tardia (FFT) do ciclo e a outra obtida na Fase Lútea (FL). Os participantes escolheram a face mais atraente e posteriormente avaliaram o grau de atratividade mediante uma escala analógica visual (VAS), cujo extremo esquerdo e direito da escala foram rotulados respectivamente por: nem um pouco atraente e muito atraente. Os resultados mostraram que a atratividade facial feminina muda em função da etapa do ciclo menstrual. As faces das mulheres que não tomavam anticoncepcionais foram julgadas como mais atraentes na etapa fértil do que na etapa infértil do ciclo. E o julgamento de atratividade feito para as faces das mulheres que tomavam anticoncepcionais não diferiram significativamente entre a FFT e a FL. Os resultados obtidos nesta pesquisa e nos estudos realizados previamente proporcionam evidências que demonstram que o período fértil nos humanos não está oculto, pois ocorrem mudanças na face que são detectáveis, mesmo quando o processo de percepção não é ciente. / Visibility of fertile period in women is a controversial topic that has been broadly discussed during the last decades. Some authors argue that ovulation became hidden in the course of evolution. In contrast, some other researchers state that ovulation in woman is not manifested as visibly as in other primates, which present very evident signals of ovulation like, e.g., vaginal tumefaction. However, several studies have provided evidence showing that fertile period in women is perceptible in a subtle way, without being aware of the perceptual process involved. Findings of those works points to the fact that some characteristics such as face, waist hip ratio, paired soft tissues symmetry and smell are perceived as more attractive in the fertile stage. The present work aimed to find out whether in any stage (late follicular or luteal) of menstrual cycle woman face appears more attractive to opposite sex, due to morphological changes induced by hormonal levels. 36 slides with frontal face photographs of woman in reproductive age were shown to male participants. In each slide two pictures of the same woman, one obtained in the late follicular phase and the other obtained in the luteal phase were exposed. Participants chose the more attractive picture and then they assessed the attractiveness through a visual analogical scale (VAS), in whose left and right extremes the legends not attractive at all and very attractive were marked, respectively. Results showed that female facial attractiveness changes as a function of the menstrual cycle stage. Faces of women who did not take contraceptives did not differ significantly between FFT and FL. The results obtained in this research and previous studies provide evidence to demonstrate that the fertile period in humans is not hidden, because on the face occur changes that are detectable even when the process of perception is not aware of.

INTRODUÇÃO: As células-tronco mesenquimais são capazes de regenerar diferentes tipos de tecidos, no entanto, a maioria dos métodos para sua obtenção são invasivos. Recentemente, foi descoberta a existência destas células no sangue menstrual. OBJETIVO: Padronizar as técnicas de coleta e transporte do fluido menstrual, bem como a caracterização, isolamento, expansão e criopreservação de células-tronco do fluido menstrual e avaliar a disponibilidade de células tronco mesenquimais no fluido menstrual. MÉTODOS: No período de agosto de 2011 a março de 2012 foram selecionadas 20 voluntárias com ciclo menstrual regular, sem doença ginecológica. O fluido menstrual foi coletado no dia de maior fluxo e submetido a imunofenotipagem e cultivo celular. Foram realizadas duas passagens em meio de cultura até atingir semi-confluência das células-tronco, as quais foram, em seguida, criopreservadas. RESULTADOS: Os parâmetros analisados apresentaram os seguintes valores médios: volume de fluido menstrual 6,90±5,60mL; tempo de transporte 17,20±5,50h; número de células totais 3,95 x106±3,88 x106 com 76,05%±24,57 de células viáveis. Após a cultura, as células mesenquimais aumentaram de 0,14%±0,26 para 96,19%±2,14. Na primeira passagem de cultura, após 15 a 21 dias, as colônias formaram grupos que atingiram a confluência, que a partir da segunda passagem ocorreu em cerca de 3 dias. As células-tronco mesenquimais criopreservadas eram viáveis. CONCLUSÃO: As células-tronco do fluido menstrual podem ser obtidas sem métodos invasivos. O fluido menstrual pode ser transportado em condições ideais de temperatura até 24 horas após a coleta. As células tronco mesenquimais podem ser caracterizadas por imunofenotipagem, isoladas, cultivadas e expandidas e, em seguida, criopreservadas. O fluido menstrual contém células tronco mesenquimais viáveis e apropriadas para cultivo / INTRODUCTION: Mesenchymal stem cells may renovate different tissues, but techniques to obtain these cells are invasive. Recently, those cells were detected in menstrual blood. OBJECTIVE: Patterning techniques of collection, transportation, characterization, isolation, expansion and cryopreservation of stem cells in menstrual fluid. METHODS: From August 2011 to March 2012 twenty volunteers were selected with regular menstrual cycle without gynecological diseases. They collected menstrual fluid on the most intense flux day to analysis by immunophenotyping and cellular culture. Culture was made in 2 stages until reached semi-confluence of stem cells and these cells were cryopreserved. RESULTS: Average of menstrual fluid volume was 6,90±5,60mL, transportation time was 17,20±5,50h, and total number of cells was 3,95 x106±3,88 x106 witch 76,05%±24,57 were viables. After culture, mesenchymal stem cells increased from 0,14%±0,26 to 96,19%±2,14. After 15 to 21 days of culture in first passage, colonies formed clusters that reached confluence. In second passage, it happens after 3 days of culture and stem cells were cryopreserved. CONCLUSION: Stem cells of menstrual fluid may be easily obtained without invasive methods. Menstrual fluid can be transported in good conditions of temperature up to 24 hours of collection. Mesenchymal stem cells of menstrual fluid may be characterized by immunophenotyping, as well as it is possible to isolated, cultivate and cryopreserved them. Menstrual fluid has viable and proper for culture mesenchymal stem cells

A visibilidade da etapa fértil na mulher é uma questão polêmica e tem sido muito discutida nas últimas décadas. Alguns autores argumentam que no transcorrer da evolução a ovulação ficou oculta. Em paralelo, outros pesquisadores afirmam que a ovulação na mulher não se manifesta de forma tão visível como em alguns primatas que apresentam sinais muito notórios da ovulação, por exemplo, a tumefação vaginal. Mas diversas pesquisas têm fornecido evidência que mostram que o período fértil na mulher é perceptível de maneira sutil, sem que se tenha consciência do processo perceptual envolvido. Os achados destas pesquisas apontam para o fato de diversas características (como a face, a proporção cintura quadril, a simetria de tecidos brandos pareados e o cheiro) serem percebidas como mais atraentes na etapa fértil. O presente estudo teve por objetivo investigar se em alguma etapa (folicular tardia ou lútea) do ciclo menstrual a face da mulher se torna mais atraente para o sexo oposto devido a mudanças morfológicas induzidas pelos níveis hormonais. Foram apresentados, apenas para participantes masculinos, 36 slides com fotografias de faces frontais de mulheres em idade reprodutiva. Em cada slide foram mostradas simultaneamente duas fotos da mesma mulher, uma das fotos obtida na Fase Folicular Tardia (FFT) do ciclo e a outra obtida na Fase Lútea (FL). Os participantes escolheram a face mais atraente e posteriormente avaliaram o grau de atratividade mediante uma escala analógica visual (VAS), cujo extremo esquerdo e direito da escala foram rotulados respectivamente por: nem um pouco atraente e muito atraente. Os resultados mostraram que a atratividade facial feminina muda em função da etapa do ciclo menstrual. As faces das mulheres que não tomavam anticoncepcionais foram julgadas como mais atraentes na etapa fértil do que na etapa infértil do ciclo. E o julgamento de atratividade feito para as faces das mulheres que tomavam anticoncepcionais não diferiram significativamente entre a FFT e a FL. Os resultados obtidos nesta pesquisa e nos estudos realizados previamente proporcionam evidências que demonstram que o período fértil nos humanos não está oculto, pois ocorrem mudanças na face que são detectáveis, mesmo quando o processo de percepção não é ciente. / Visibility of fertile period in women is a controversial topic that has been broadly discussed during the last decades. Some authors argue that ovulation became hidden in the course of evolution. In contrast, some other researchers state that ovulation in woman is not manifested as visibly as in other primates, which present very evident signals of ovulation like, e.g., vaginal tumefaction. However, several studies have provided evidence showing that fertile period in women is perceptible in a subtle way, without being aware of the perceptual process involved. Findings of those works points to the fact that some characteristics such as face, waist hip ratio, paired soft tissues symmetry and smell are perceived as more attractive in the fertile stage. The present work aimed to find out whether in any stage (late follicular or luteal) of menstrual cycle woman face appears more attractive to opposite sex, due to morphological changes induced by hormonal levels. 36 slides with frontal face photographs of woman in reproductive age were shown to male participants. In each slide two pictures of the same woman, one obtained in the late follicular phase and the other obtained in the luteal phase were exposed. Participants chose the more attractive picture and then they assessed the attractiveness through a visual analogical scale (VAS), in whose left and right extremes the legends not attractive at all and very attractive were marked, respectively. Results showed that female facial attractiveness changes as a function of the menstrual cycle stage. Faces of women who did not take contraceptives did not differ significantly between FFT and FL. The results obtained in this research and previous studies provide evidence to demonstrate that the fertile period in humans is not hidden, because on the face occur changes that are detectable even when the process of perception is not aware of.

Anorexia nervosa e transtorno alimentar não especificado (TANE) são os transtornos alimentares mais frequentes na adolescência. Cursam com alterações hormonais e amenorreia. Este projeto tem como objetivo a maior compreensão das alterações laboratoriais e hormonais que ocorrem concomitantemente com esses transtornos alimentares na adolescência, em especial a relação com o retorno dos ciclos menstruais, a recuperação nutricional e a secreção de leptina e IGF-1. Vinte e oito adolescentes do sexo feminino, portadoras de anorexia nervosa ou TANE foram submetidas a coletas de amostras de sangue para dosagem de leptina, LH, FSH, PRL, estradiol, GH, IGF-1, TSH, T4L, T4, T3, proteínas totais e frações, função renal, hemograma, ferro, ferritina e eletrólitos no início do estudo e a cada cinco semanas num total de cinco coletas. Densitometria óssea foi realizada no início do acompanhamento e após seis meses para avaliar comprometimento ósseo. As principais complicações clínicas observadas foram amenorreia (78%) e osteoporose (14,8%). No início do estudo, 12 pacientes encontravam-se desnutridas com z score de IMC -2. As alterações hormonais presentes foram: diminuição do T3, estradiol, leptina, LH e IGF-1. As pacientes evoluíram com boa recuperação nutricional (variação da média de IMC ao longo do estudo IMC p < 0,01) e melhora dos parâmetros clínicos e hormonais. O IGF-1 apresentou-se como o melhor marcador de recuperação nutricional (p = 0,0001) e teve boa correlação com o retorno menstrual. À época do retorno menstrual as pacientes apresentaram IGF-1 > 340ng/mL (p = 0,04) / Anorexia Nervosa (AN) and eating disorder not otherwise specified (EDNOS) are the most frequent eating disorders in adolescence. The patients show hormonal alterations as well as amenorrhea. The aim of this study was to improve the knowledge of hormonal disturbances that occur together with AN and EDNOS, especially with regard to menstrual cycles, nutritional recovery as well as leptin and IGF-1 secretion. Twenty eight female adolescents with AN or EDNOS had blood collected for the following dosages: leptin, LH, FSH, PRL, estradiol, GH, IGF-1, TSH, FT4, T4, T3, total proteins and fractions, renal function, CBC, iron , ferritin, electrolytes in the beginning of the study and at every 5 weeks totalizing 5 samples per patient. Bone densitometry was performed at the start and after 6 months. The main clinical complications were amenorrhea (78%) and osteoporosis (14.8%). Twelve patients were undernourished at the start of the study (BMI z score = -2). Hormonal alterations were low T3, estradiol, leptina, LH, and IGF-1. The patients had good nutritional recovery, evaluated as a variation of BMI (p < 0.001) and improved clinical and hormonal parameters. IGF-I was the best marker of nutritional recovery (p = 0.0001) and correlated very well with menstrual cycles recovery. At the time when the patients resumed menstrual cycles, IGF-1 was above 340ng/mL (p = 0.04)

Anorexia nervosa e transtorno alimentar não especificado (TANE) são os transtornos alimentares mais frequentes na adolescência. Cursam com alterações hormonais e amenorreia. Este projeto tem como objetivo a maior compreensão das alterações laboratoriais e hormonais que ocorrem concomitantemente com esses transtornos alimentares na adolescência, em especial a relação com o retorno dos ciclos menstruais, a recuperação nutricional e a secreção de leptina e IGF-1. Vinte e oito adolescentes do sexo feminino, portadoras de anorexia nervosa ou TANE foram submetidas a coletas de amostras de sangue para dosagem de leptina, LH, FSH, PRL, estradiol, GH, IGF-1, TSH, T4L, T4, T3, proteínas totais e frações, função renal, hemograma, ferro, ferritina e eletrólitos no início do estudo e a cada cinco semanas num total de cinco coletas. Densitometria óssea foi realizada no início do acompanhamento e após seis meses para avaliar comprometimento ósseo. As principais complicações clínicas observadas foram amenorreia (78%) e osteoporose (14,8%). No início do estudo, 12 pacientes encontravam-se desnutridas com z score de IMC -2. As alterações hormonais presentes foram: diminuição do T3, estradiol, leptina, LH e IGF-1. As pacientes evoluíram com boa recuperação nutricional (variação da média de IMC ao longo do estudo IMC p < 0,01) e melhora dos parâmetros clínicos e hormonais. O IGF-1 apresentou-se como o melhor marcador de recuperação nutricional (p = 0,0001) e teve boa correlação com o retorno menstrual. À época do retorno menstrual as pacientes apresentaram IGF-1 > 340ng/mL (p = 0,04) / Anorexia Nervosa (AN) and eating disorder not otherwise specified (EDNOS) are the most frequent eating disorders in adolescence. The patients show hormonal alterations as well as amenorrhea. The aim of this study was to improve the knowledge of hormonal disturbances that occur together with AN and EDNOS, especially with regard to menstrual cycles, nutritional recovery as well as leptin and IGF-1 secretion. Twenty eight female adolescents with AN or EDNOS had blood collected for the following dosages: leptin, LH, FSH, PRL, estradiol, GH, IGF-1, TSH, FT4, T4, T3, total proteins and fractions, renal function, CBC, iron , ferritin, electrolytes in the beginning of the study and at every 5 weeks totalizing 5 samples per patient. Bone densitometry was performed at the start and after 6 months. The main clinical complications were amenorrhea (78%) and osteoporosis (14.8%). Twelve patients were undernourished at the start of the study (BMI z score = -2). Hormonal alterations were low T3, estradiol, leptina, LH, and IGF-1. The patients had good nutritional recovery, evaluated as a variation of BMI (p < 0.001) and improved clinical and hormonal parameters. IGF-I was the best marker of nutritional recovery (p = 0.0001) and correlated very well with menstrual cycles recovery. At the time when the patients resumed menstrual cycles, IGF-1 was above 340ng/mL (p = 0.04)

Energy intake (EI) and energy expenditure (EE) across the menstrual cycle (MC), while considering body adiposity, have not been previously evaluated in the same individuals. This study mainly examined the variations in energy balance (EB) across MC. Seventeen women (Body fat-DXA:28.5%) participated in three identical sessions during distinct phases of the MC: Early-follicular, Late-follicular/ovulation and Mid-luteal (confirmed by basal temperature and sex-steroid hormones). EI, resting metabolic rate (RMR), physical-activity EE (PAEE), severity of PMS, leptin and relative-reinforcing value (RRV) of preferred foods were measured during each phase. No differences in body fat, EI, RMR, PAEE, leptin and RRV of food were noted across MC. Trends were noted in preferred snack (p=0.06) and combined snack/fruit (p=0.06) intakes, while differences were noted in severity of PMS (p<0.05) across phases. Changes in EB across the MC were not noted. PMS was more severe, and preferred snack and combined snack/fruit intakes were slightly higher during mid-luteal phase.